Kensey Nash Angio-Seal
This article was originally published in The Gray Sheet
Executive Summary
Hemostatic puncture closure system includes sizes 6F and 8F following FDA market go-ahead for the smaller version, granted to marketing partner St. Jude Medical and announced March 9. The 6F device, which addresses the market for punctures created during diagnostic catheterization procedures, gives St. Jude and Kensey Nash access to approximately 70% of the 6.5 mil. procedures performed through a 6F or smaller puncture in the femoral artery, Kensey Nash notes. An immediate launch of the Kensey Nash-made device through St. Jude's Daig division is anticipated
You may also be interested in...
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.